Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hong Kong Science and Technology Parks Corporation (HKSTP) is a statutory body established by the Hong Kong SAR Government to foster a vibrant innovation and technology (I&T) ecosystem. It operates the Hong Kong Science Park, which serves as a major hub for over 300 life science and health technology companies, providing world-class laboratory infrastructure, funding, and regulatory support. HKSTP's flagship Incu-Bio program is a dedicated incubator for biotech startups, offering end-to-end assistance from laboratory research to clinical trials and commercialization. The corporation acts as a strategic catalyst, connecting innovators with global investors, academic institutions, and pharmaceutical partners to accelerate the translation of medical breakthroughs. By leveraging Hong Kong's position as a leading biotech fundraising hub, HKSTP facilitates multi-billion dollar deals and IPO pipelines for its portfolio companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Technology Parks.